Home / Children and Childhood / Coronavirus (2019-nCoV) / Coronavirus Omicron Variant / Vaccination and Immunization / Omicron’s surge helped clarify the Pfizer vaccine’s efficacy in young children, a company board member says.

Omicron’s surge helped clarify the Pfizer vaccine’s efficacy in young children, a company board member says.

The Guardian Express Monday, February 07, 2022 Children and Childhood, Coronavirus (2019-nCoV), Coronavirus Omicron Variant, Vaccination and Immunization

https://ift.tt/Sp04GUA

At the urging of the federal government, Pfizer and its partner BioNTech applied last week for authorization for two doses of its Covid vaccine to children aged 4 and younger. By BY MATT RICHTEL from NYT https://ift.tt/Sp04GUA

No comments

Subscribe to: Post Comments ( Atom )